Skip to main content
ATS
NYSE Technology

ATS Swings to C$5.0M Q2 Loss, Scraps FY27 Growth and Margin Targets on Tariff Delays

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial Machinery Stocks · Industrial
Sentiment info
Negative
Importance info
8
Price
$18.96
Mkt Cap
$1.86B
52W Low
$17.15
52W High
$35.82
52W Position info
11% above low
Off High info
47% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

ATS is trading near its 52-week low of $17.15 (11% above the low).

Summary

ATS posted a C$5.0M net loss on 8.6% lower revenue and withdrew its fiscal 2027 growth and margin targets, blaming tariff-driven delays in non-life sciences orders; bookings rose 12.7% to C$827M and Q3 revenue is guided to C$640M-C$680M.


Key Events · Earnings and Guidance · ATS

  • Q2 Loss as Revenue Falls 8.6%

    Revenue was C$665.8M versus C$728.5M a year ago and net income swung to a C$5.0M loss (5 cents per share) from C$33.6M of income (34 cents); adjusted EBITDA fell 22.2% to C$80.7M.

  • FY2027 Targets Withdrawn

    Management no longer expects modest revenue growth or 50-75 bps of margin expansion in fiscal 2027, citing delayed non-life sciences bookings and backlog conversion timing; Q3 revenue is guided to C$640M-C$680M.

  • Tariffs Hit Packaging Orders

    Section 338 tariffs effective late August 2026 on Canadian-made packaging equipment sold into the U.S. worsened customer deferrals; the late-October U.S. modification eliminates the impact on a majority of covered products.

  • Bookings Up 12.7% to C$827M

    Order bookings rose to C$827M from C$734M, with the highest life sciences quarterly total since Q2 FY2025 and a trailing-twelve-month book-to-bill of about 1.05:1; backlog was C$2,009M, down 2.9%.


Analysis · ATS · Technology

ATS flipped from C$33.6M of net income a year ago to a C$5.0M net loss as revenue fell 8.6% to C$665.8M, and management formally abandoned its fiscal 2027 goals of modest revenue growth and 50-75 bps of margin expansion. The culprit is a timing shift in non-life sciences orders — packaging automation in particular — made worse by Section 338 tariffs that hit Canadian-made equipment sold into the U.S. from late August. The offsetting positives are real: order bookings rose 12.7% to C$827M on record life sciences backlog, and the late-October tariff modification removes the impact on most covered products. But the near-term math is ugly — Q3 revenue is guided to C$640M-C$680M, below the current run rate, and net debt at 3.1x pro forma adjusted EBITDA sits above the 2.0-3.0x target after C$61.3M of buybacks. The C$65M-C$75M Fixed Cost Transformation savings are the main lever to rebuild margin toward the 15% long-term target.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ATS was trading at $18.96 on NYSE in the Technology sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $17.15 to $35.82. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ATS - Latest Insights

ATS
Nov 04, 2026, 6:00 AM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $18.96
Real-time Price: $17.80 info
Change: -$1.16 (-6%) info
Market Cap: $1.707B info
ATS
Aug 06, 2026, 7:08 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $25.22
Real-time Price: $17.80 info
Change: -$7.42 (-29%) info
Market Cap: $1.707B info
ATS
Aug 06, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $27.00
Real-time Price: $17.80 info
Change: -$9.20 (-34%) info
Market Cap: $1.707B info
ATS
Jul 02, 2026, 5:14 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $27.68
Real-time Price: $17.80 info
Change: -$9.88 (-36%) info
Market Cap: $1.707B info
ATS
May 28, 2026, 8:37 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $32.36
Real-time Price: $17.80 info
Change: -$14.56 (-45%) info
Market Cap: $1.707B info